COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,707 | -27.4% | 456,585 | -17.1% | 0.00% | -33.3% |
| Q2 2023 | $2,350 | -8.9% | 550,523 | +45.9% | 0.00% | 0.0% |
| Q1 2023 | $2,580 | +2.5% | 377,333 | +18.8% | 0.00% | 0.0% |
| Q4 2022 | $2,516 | -99.8% | 317,722 | +97.4% | 0.00% | +50.0% |
| Q3 2022 | $1,546,000 | +2520.3% | 160,976 | +1857.9% | 0.00% | – |
| Q2 2022 | $59,000 | -80.0% | 8,222 | -64.1% | 0.00% | – |
| Q1 2022 | $295,000 | -60.1% | 22,888 | -50.6% | 0.00% | -100.0% |
| Q4 2021 | $740,000 | +487.3% | 46,374 | +491.3% | 0.00% | – |
| Q3 2021 | $126,000 | -59.0% | 7,843 | -64.7% | 0.00% | – |
| Q2 2021 | $307,000 | -75.3% | 22,217 | -73.9% | 0.00% | -100.0% |
| Q1 2021 | $1,242,000 | +19.3% | 85,076 | +42.0% | 0.00% | +100.0% |
| Q4 2020 | $1,041,000 | +47.9% | 59,897 | +22.0% | 0.00% | 0.0% |
| Q2 2017 | $704,000 | – | 49,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |